We observed that the onset of ALS, as measured by weight loss and performance scores, was delayed in sRAGE-treated SOD1 mice and that these mice had improved motor functional scores and prolonged life span. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.